Skip to main content
NIH funding notice PA-12-083

Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21)

Closed on May 7, 2015.

Posted
January 17, 2012
Close date
May 7, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $617,239 in first-year total cost, median $198,128.

Most frequent study sections

  1. Somatosensory and Chemosensory Systems Study Section[SCS]2
  2. Neurogenesis and Cell Fate Study Section[NCF]1

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. STANFORD UNIVERSITY1
  3. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
Competing awards under PA-12-083 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Hedgehog signaling in taste cell maintenance and regeneration1R21NS093556-01BEACHY, PHILIP ASTANFORD UNIVERSITY, CA$254,627NCF
2015Treating chemotherapy-induced neuropathic pain by targeted silencing of A-fibers1R21NS091779-01XU, ZHEN-ZHONGDUKE UNIVERSITY, NC$198,128SCS
2015Cellular Mechanisms of Chemotherapy-Induced Peripheral Neuropathy1R21CA194138-01EATON, BENJAMIN ARTHURHARGREAVES, KENNETH MSTOCKAND, JAMES DUNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX$164,484SCS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-12-083: Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21) | ScienceDex | ConductScience